Announcements

New Report Provides Clear and Clinically Meaningful Results

Only the Oncotype DX Breast DCIS Score report integrates clinicopathological features to provides an individualized risk assessment of 10-year local recurrence for DCIS patients. No other test can help you navigate the complexities of DCIS risk management to personalize your patient's treatment plan.

The Breast DCIS Score report:

  • QUANTIFIES 10-year risk of any local recurrence or an invasive local recurrence
  • CONFIRMED in a meta-analysis involving 773 patients
  • REFINED risk estimates with specified clinicopathologic features
  • INCREASES clarity and confidence in your patient's personalized treatment plan
  •  

    Oncotype DX Breast DCIS Score Report and Meta-Analysis Overview

    Our Director of Medical Affairs explains how the addition of tumor size and patient age increases the prognostic power of the Breast DCIS Score.

     

    SAMPLE REPORT

    1

    Visual representation of DCIS Score result and overview of risk estimate

    2

    Patient's 10year risk of local recurrence, based on patient's age, tumor size, and DCIS Score result

    3

    Redefined risk of recurrence - any local recurrence (DCIS or invasive) and invasive local recurrence

    DCIS Score Report - Page 1
    1

    Delivers quantitative single-gene scores for informed hormone therapy decision-making

    DCIS Score Report - Page 2
    1

    Patient-friendly language to help explain the results to patients

    2

    Visual representation of patient's personalized risk of local recurrence

    3

    Notes section to facilitate patient discussions and treatment decisions

    4

    Web address where patients can join the MyOncotype.com patient network

    DCIS Score Report - Page 3

    Do You Have a Question?

    Contact Us

    Meta-Analysis

    Rakovitch et al. pooled data from 2 validation studies to refine estimates of local recurrence based on age and tumor size.

    Get ASCO Poster

    Stay in Touch

    Have a specific question? Want to keep up with our latest news? We're here for you.

    Contact Us
    Making cancer care smarter.™